M&T Bank Corp increased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 9.4% during the 4th ...
United Therapeutics will sponsor the Tyvaso DPI®: Clinical Pearls and Drug-Device Characteristics Sympo SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., September 10, 2024--United Therapeutics ...
United Therapeutics’ Q4 earnings brought clarity on the outlook for the base commercial business and Tyvaso’s future growth trajectory, suggesting that gross-to-net impact from recent ...
As of 12:24:43 pm GMT-4. Market open. Loading Chart for MNKD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback